MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-22-2025
IQVIA Holdings Cash and Cash Equivalents 2011-2026 | IQV
Annual Cash and Cash Equivalents IQVIA Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.7 B | 1.38 B | 1.22 B | 1.37 B | 1.81 B | 837 M | 891 M | 959 M | 1.2 B | 977 M | 867 M | 778 M | 568 M | 516 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.81 B | 516 M | 1.08 B |
Quarterly Cash and Cash Equivalents IQVIA Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.04 B | 1.74 B | 1.7 B | 1.57 B | 1.54 B | 1.44 B | 1.38 B | 1.22 B | 1.38 B | 1.49 B | 1.22 B | 1.27 B | 1.43 B | 1.39 B | 1.37 B | 1.47 B | 1.81 B | 2.3 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 837 M | 837 M | 837 M | 837 M | 891 M | 891 M | 891 M | 891 M | 959 M | 959 M | 959 M | 959 M | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 977 M | 977 M | 977 M | 977 M | 867 M | 867 M | 867 M | 867 M | 777 M | 778 M | 778 M | 778 M | 568 M | 568 M | 568 M | 568 M | 516 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.3 B | 516 M | 1.16 B |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
69.3 M | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Co-Diagnostics
CODX
|
14.9 M | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Danaher Corporation
DHR
|
2.08 B | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
566 M | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
BioNano Genomics
BNGO
|
9.17 M | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
36.8 M | $ 11.38 | 6.36 % | $ 323 M | Israel |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
601 M | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
CareDx, Inc
CDNA
|
82.2 M | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
Celcuity
CELC
|
22.5 M | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
Myriad Genetics
MYGN
|
102 M | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
NeoGenomics
NEO
|
367 M | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
National Research Corporation
NRC
|
6.65 M | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Anixa Biosciences
ANIX
|
1.27 M | $ 3.12 | - | $ 99.5 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.4 B | $ 27.08 | -1.13 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
1.5 M | $ 22.98 | -1.84 % | $ 29.8 M | USA |
 |
Personalis
PSNL
|
91.4 M | $ 7.96 | -0.13 % | $ 472 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | $ 44.97 | -0.77 % | $ 10 B | Niderland |
 |
Guardant Health
GH
|
526 M | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
RadNet
RDNT
|
740 M | $ 71.35 | -0.2 % | $ 5.21 B | USA |
 |
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | USA |
 |
Soleno Therapeutics
SLNO
|
87.9 M | $ 46.3 | 0.02 % | $ 1.86 B | USA |
 |
ENDRA Life Sciences
NDRA
|
3.23 M | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
195 M | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
Thermo Fisher Scientific
TMO
|
4.01 B | $ 579.45 | -0.69 % | $ 221 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.79 | -3.54 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 31.72 | -1.34 % | $ 1.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
549 M | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
26.2 M | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |